Cancer Reform Strategy - NHS Cancer Screening Programmes

More documents

Recommendations

Info

116 CANCER REFORM STRATEGYthose plans into the reality of clinical services onthe ground. Three year planning was found tobe weak in more than half of networks. Furtherwork is required to ensure that effectivecollective commissioning arrangements are inplace in all networks.9.30 Full information on the compliance ofindividual teams and services with the peerreview measures is available to commissionersand providers on the CQUINS website. Work isongoing to make this website more accessibleand user-friendly.9.31 An independent evaluation of the cancerpeer review programme has demonstratedstrong support for the programme to continue,but has also indicated that the programmeshould be modified. At present peer reviewfocuses largely on measures of structure andprocess. Over time, as reliable measures ofoutcome become available, there should be ashift in emphasis. In addition we have listenedto the concerns of reviewers and those beingreviewed about the burden of inspection.To reduce this, the peer review programmewill focus more on annual self assessment.Self-assessments made by individual teamsand services will need to be signed off bythe relevant provider CEO and by thecancer network. Some external visits willcontinue, but this will become theexception rather than the rule once a teamhas demonstrated a high level ofcompliance with the measures. Peer reviewdata will continue to be published to assistcommissioners and promote transparencyon service performance.●●●●Some complex cancer surgery currently fallsunder the same Healthcare Resource Group(HRG) as less complex non-cancerprocedures. As the tariff price for that HRG isbased on the average costs of all procedureswithin that HRG, the complex cancer workwill therefore be under rewarded and therewill be no incentive for trusts to specialise indoing this activity;There will be no motivation for acute truststo cease providing simple care and focus onmore complex cases if the tariff is notadjusted to reflect a more difficult and costintensive case mix in secondary care;There is a lack of clarity as to how MDTplanning meetings are reimbursed; andThe tariff is meant to cover capital costs,however it cannot take account of the highvariation in the cost of installing newbunkers for radiotherapy.9.33 To ensure that tariffs appropriatelyincentivise good practice and do not penaliseinnovation, we commissioned a review of cancertariffs. The review looked at both how cancer istreated under the current HRGs (HRGv3.5),which will be used for payment in 2008/09 andthe next version of HRGs, HRG4, which willestablish new national currencies forradiotherapy, chemotherapy and specialistpalliative care. This review identified thefollowing key issues as particular priorities ifPbR is to effectively support cancer services:●Improving coding quality and consistency;Ensuring that tariffs supportservice improvements9.32 The funding mechanism for cancer servicesshould recognise and incentivise appropriate andeffective care. At present, there is someevidence that the Payment by Results (PbR)tariffs are not always achieving this objective.For example:●●●●Ensuring fair payment for MDTs;Ensuring that the HRG4 structure works forfunding chemotherapy;Improving funding of outpatient cancer care;Ensuring fair payment for the highly complexcancer procedures; and●Supporting investment in new technologyand capital such as radiotherapy bunkers.
CHAPTER 9: STRONGER COMMISSIONING 1179.34 As a result the Department of Health will:●●●●Improve high level guidance, including theneed for robust costing of MDTs to helpcommissioning;Make use of expert panels for cancer servicesto ensure HRG4 is fit for purpose;Investigate the feasibility of normativeadjustments to cancer tariffs, or a separateor a separate outpatient tariff for cancer inkey specialties. This may help both with theproblems of reimbursing complex cancersurgery and recognising the need forMultidisciplinary Assessments as part of afirst outpatient appointment; andKeep the relationship between capitalexpenditure and the tariff under review.
Page 1:
Cancer Reform Strategy
Page 4 and 5:
DH INFORMATION READER BOXPolicyHR/W
Page 7:
3Forewordby the Prime MinisterAt on
Page 10 and 11:
6 CANCER REFORM STRATEGY9. Your NHS
Page 12 and 13:
8 CANCER REFORM STRATEGY9. Excessiv
Page 14 and 15:
10 CANCER REFORM STRATEGYWe will al
Page 16 and 17:
What the Cancer Reform Strategy mea
Page 18 and 19:
14 CANCER REFORM STRATEGY●●●R
Page 21 and 22:
17Chapter 1:The challenge of cancer
Page 23 and 24:
CHAPTER 1: THE CHALLENGE OF CANCER
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33:
Page 37 and 38:
33Chapter 2:Preventing cancerChapte
Page 39 and 40:
CHAPTER 2: PREVENTING CANCER 352.15
Page 41 and 42:
CHAPTER 2: PREVENTING CANCER 37Nico
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
43Chapter 3:Diagnosing cancer earli
Page 49 and 50:
CHAPTER 3: DIAGNOSING CANCER EARLIE
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
CHAPTER 4: ENSURING BETTER TREATMEN
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70: CHAPTER 4: ENSURING BETTER TREATMEN
Page 75 and 76: CHAPTER 5: LIVING WITH AND BEYOND C
Page 89 and 90: CHAPTER 6: REDUCING CANCER INEQUALI
Page 97 and 98: 93Chapter 7:Delivering care in the
Page 99 and 100: CHAPTER 7: DELIVERING CARE IN THE M
Page 107: Part 3:Ensuring delivery andmaintai
Page 110 and 111: 106 CANCER REFORM STRATEGY●Clinic
Page 112 and 113: 108 CANCER REFORM STRATEGYCoordinat
Page 114 and 115: 110Chapter 9:Stronger commissioning
Page 116 and 117: 112 CANCER REFORM STRATEGY9.12 Canc
Page 118 and 119: 114 CANCER REFORM STRATEGYBox 47: W
Page 122 and 123: 118Chapter 10:Funding world class c
Page 124 and 125: 120 CANCER REFORM STRATEGYsector (i
Page 126 and 127: 122 CANCER REFORM STRATEGYimportant
Page 128 and 129: 124Chapter 11:Building for the futu
Page 130 and 131: 126 CANCER REFORM STRATEGY11.8 Serv
Page 132 and 133: 128 CANCER REFORM STRATEGYservices
Page 134 and 135: 130 CANCER REFORM STRATEGY11.33 Loo
Page 137 and 138: Annexes
Page 139 and 140: 135Annex 2:References1 Cancer is ou
Page 141: ANNEX 2: REFERENCES 13737 K. Moser,
show all

Cancer Reform Strategy - NHS Cancer Screening Programmes

Create successful ePaper yourself

Delete template?

Save as template?